Found: 14
Select item for more details and to access through your institution.
A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 11, p. 2285, doi. 10.1007/s40121-024-01034-w
- By:
- Publication type:
- Article
HIV rebound in HIV controllers is associated with a specific fecal microbiome profile.
- Published in:
- European Journal of Immunology, 2024, v. 54, n. 8, p. 1, doi. 10.1002/eji.202350809
- By:
- Publication type:
- Article
Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 970, doi. 10.3390/pharmaceutics14050970
- By:
- Publication type:
- Article
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 6, p. 752, doi. 10.1111/apt.17878
- By:
- Publication type:
- Article
Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036402
- By:
- Publication type:
- Article
Follicular Helper T (T<sub>FH</sub>) Cell Targeting by TLR8 Signaling For Improving HBsAg-Specific B Cell Response In Chronic Hepatitis B Patients.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.735913
- By:
- Publication type:
- Article
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12624, doi. 10.1038/ncomms12624
- By:
- Publication type:
- Article
Oral Selective TLR8 Agonist Selgantolimod Induces Multiple Immune Cell Responses in Humans.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 12, p. 2400, doi. 10.3390/v13122400
- By:
- Publication type:
- Article
Remdesivir in an outpatient setting improves biomarkers for progression of COVID-19.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S358
- By:
- Publication type:
- Article
Nuclear Phospho-Akt Increase Predicts Synergy of PI3K Inhibition and Doxorubicin in Breast and Ovarian Cancer.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 48, p. 1, doi. 10.1126/scitranslmed.3000630
- By:
- Publication type:
- Article
VESATOLIMOD PHARMACODYNAMIC RESPONSE IS ASSOCIATED WITH TIME TO HIV REBOUND.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 173
- By:
- Publication type:
- Article
Prognostic value of severe acute respiratory syndrome coronavirus‐2 viral load and antibodies in patients hospitalized with COVID‐19.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 6, p. 1049, doi. 10.1111/cts.13511
- By:
- Publication type:
- Article
Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimod.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1405348
- By:
- Publication type:
- Article
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 599, p. 1, doi. 10.1126/scitranslmed.abg3071
- By:
- Publication type:
- Article